Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Survival rates of systemic interventions for psoriasis in the Western Japan Psoriasis Registry: A multicenter retrospective study.
Yanase T, Tsuruta N, Yamaguchi K, Ohata C, Ohyama B, Katayama E, Sugita K, Kuwashiro M, Hashimoto A, Yonekura K, Higashi Y, Murota H, Koike Y, Matsuzaka Y, Kikuchi S, Hatano Y, Saito K, Takahashi K, Miyagi T, Kaneko S, Ota M, Harada K, Morizane S, Ikeda K, Furue M, Nakahara T, Okazaki F, Sasaki N, Okada E, Yoshida Y, Ito K, Imafuku S. Yanase T, et al. Among authors: katayama e. J Dermatol. 2023 Jun;50(6):753-765. doi: 10.1111/1346-8138.16737. Epub 2023 Feb 14. J Dermatol. 2023. PMID: 36786158
Angiotropic syringomatous carcinoma.
Katayama E, Saruta H, Nanri A, Nakama T, Ohata C. Katayama E, et al. J Cutan Pathol. 2017 Apr;44(4):397-400. doi: 10.1111/cup.12893. Epub 2017 Feb 7. J Cutan Pathol. 2017. PMID: 28075031
Cutaneous Histiocytic Sarcoma With Cellular Cannibalism.
Nanri A, Katayama E, Imamura T, Muto I, Saruta H, Akiba J, Ohshima K, Nakama T, Ohata C. Nanri A, et al. Among authors: katayama e. Am J Dermatopathol. 2020 Apr;42(4):286-291. doi: 10.1097/DAD.0000000000001525. Am J Dermatopathol. 2020. PMID: 31567137
Clinical characteristics of patients with psoriasis with family history: A multicenter observational study.
Ohata C, Anezaki H, Kaneko S, Okazaki F, Ito K, Matsuzaka Y, Kikuchi S, Koike Y, Murota H, Miyagi T, Takahashi K, Sugita K, Hashimoto A, Nakahara T, Morizane S, Ohyama B, Saruwatari H, Yanase T, Yoshida Y, Yonekura K, Higashi Y, Hatano Y, Saito K, Katayama E, Yamane M, Yamazaki F, Tsuruta N, Imafuku S. Ohata C, et al. Among authors: katayama e. J Dermatol. 2023 Jun;50(6):746-752. doi: 10.1111/1346-8138.16733. Epub 2023 Jan 24. J Dermatol. 2023. PMID: 36694440
Efficacy of Nivolumab and Ipilimumab Combined Therapy as a First-Line Therapy for Patients with Advanced Melanoma and the Urgent Need for an Effective Second-Line Therapy for Patients with Wild-Type BRAF in Japan: A Single Center Retrospective Study.
Muto I, Koga H, Doi R, Katayama E, Nakama K, Nakama T. Muto I, et al. Among authors: katayama e. Kurume Med J. 2023 Nov 30;69(1.2):75-80. doi: 10.2739/kurumemedj.MS6912008. Epub 2023 Oct 3. Kurume Med J. 2023. PMID: 37793888 Free article.
199 results